Pimivalimab

Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor[1].

Product Specifications

CAS Number

[2293951-22-9]

Product Name Alternative

JTX-4014

UNSPSC

12352203

Target

PD-1/PD-L1

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/pimivalimab.html

Purity

97.87

Solubility

10 mM in DMSO

Smiles

[Pimivalimab]

Molecular Weight

(144.9 kDa)

References & Citations

[1]K. Papadopoulos, et al. 172P Phase I study of JTX-8064, a LILRB2 (ILT4) inhibitor, as monotherapy and combination with pimivalimab (pimi), a PD-1 inhibitor (PD-1i), in patients (pts) with advanced solid tumors. VOLUME 16, SUPPLEMENT 1, 100284, DECEMBER 01, 2022.